You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

In Re Pfizer Inc. Shareholder Derivative Litig.

Citations: 780 F. Supp. 2d 331; 2011 U.S. Dist. LEXIS 45867; 2011 WL 1641306Docket: Master File No. 09 Civ. 7822(JSR)

Court: District Court, S.D. New York; April 28, 2011; Federal District Court

Narrative Opinion Summary

In this case, Dr. Lawrence Bezidijian sought to intervene and claim attorneys' fees in the Pfizer Inc. Shareholder Derivative Litigation. The litigation involved shareholder complaints against Pfizer's directors and executives following a $2.3 billion settlement for illegal marketing practices. Bezidijian had previously sent a demand letter to Pfizer's Board seeking corporate governance reforms, which the Board declined to act on. Despite this, he did not pursue the matter further while the main parties engaged in extensive litigation, leading to a settlement approved by the Court in December 2010. Bezidijian's motion to intervene was filed in February 2011, shortly before the final approval hearing for the settlement, raising suspicions about his motives. The Court denied his motion to intervene as of right, citing untimeliness and lack of contribution to the litigation. His request for permissive intervention was also dismissed for similar reasons. Furthermore, the Court found his claim for attorneys' fees lacked merit, as he failed to establish a causal connection between his demand letter and the settlement benefits under Delaware law. Consequently, the Court denied all of Bezidijian's motions by Order dated February 28, 2011.

Legal Issues Addressed

Attorneys' Fees in Derivative Actions under Delaware Law

Application: Bezidijian failed to show a causal link between his demand letter and the corporation's beneficial actions, thus not meeting the burden of proof required to claim attorneys' fees.

Reasoning: Bezidijian failed to establish any causal connection between his demand letter and Pfizer's settlement plans. Typically, the burden of proof for causation rests with the shareholder seeking fees, not the corporation.

Causation Requirement for Attorneys' Fees

Application: The court emphasized the necessity of a causal link between the shareholder's actions and the corporation's beneficial outcome, which Bezidijian could not demonstrate.

Reasoning: Evidence suggests Bezidijian's letter did not contribute to the benefits outlined in the proposed settlement, as it lacked specific demands for corporate changes.

Intervention as of Right under Rule 24

Application: The court found Bezidijian's motion to intervene was untimely because he waited over a year to file his motion after being aware of the proceedings, suggesting his intent was solely to claim attorneys' fees.

Reasoning: Bezidijian did not engage in over a year of proceedings despite being aware of them and only filed to intervene after a proposed settlement was tentatively approved, just weeks before the final approval hearing.

Permissive Intervention

Application: Bezidijian's motion for permissive intervention was dismissed as untimely despite acknowledging shared legal and factual questions with the main case.

Reasoning: Regarding his motion for permissive intervention, although there was acknowledgment of shared legal and factual questions, it was also deemed untimely for the same reasons and dismissed.

Timeliness of Intervention

Application: The court exercised its discretion to determine the untimeliness of Bezidijian's motion to intervene based on the totality of circumstances, including his inaction over a significant period.

Reasoning: The Court noted that the determination of timeliness is at its discretion, based on the totality of circumstances.